1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
Original Article
You have full text access to this OnlineOpen article
Delay to institution of therapy and induction of remission using single-drug or combination–disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
Article first published online: 5 APR 2002
DOI: 10.1002/art.10135
Copyright © 2002 by the American College of Rheumatology
1529-0131/asset/cover.gif?v=1&s=104d5c2bb8ef72deba26790b855af7ab80697a0e "Arthritis & Rheumatism")
Additional Information
How to Cite
Möttönen, T., Hannonen, P., Korpela, M., Nissilä, M., Kautiainen, H., Ilonen, J., Laasonen, L., Kaipiainen-Seppänen, O., Franzen, P., Helve, T., Koski, J., Gripenberg-Gahmberg, M., Myllykangas-Luosujärvi, R. and Leirisalo-Repo, M. (2002), Delay to institution of therapy and induction of remission using single-drug or combination–disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis & Rheumatism, 46: 894–898. doi: 10.1002/art.10135
Publication History
- Issue published online: 5 APR 2002
- Article first published online: 5 APR 2002
- Manuscript Accepted: 24 OCT 2001
- Manuscript Received: 25 MAY 2001
Funded by
- Finnish Society for Rheumatology
- Medical Research Foundation of Turku University Central Hospital
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , ¿Son útiles los factores pronóstico en la artritis reumatoide?, ReumatologÃa ClÃnica, 2011, 7, 5, 339
- 2, , , , Advances in early inflammatory arthritis: IP85. Genetic and Environmental Risk Factors in Early Rheumatoid Arthritis, Rheumatology, 2011, 50, Supplement 3, iii21
- 3, , Are Prognostic Factors Useful in Rheumatoid Arthritis?, Reumatolog Ãa Cl Ãnica (English Edition), 2011,
- 4, , Decreasing time to treatment in rheumatoid arthritis: review of delays in presentation, referral and assessment, International Journal of Clinical Rheumatology, 2011, 6, 2, 173
- 5, , , , , , , Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: Results from the Consortium of Rheumatology Researchers of North America registry, Arthritis Care & Research, 2011, 63, 6Direct Link:
- 6, , , Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis, Arthritis Care & Research, 2011, 63, 5Direct Link:
- 7, , , , , , , , , , , , , , , , , , , Strategien zur verbesserten Versorgung von Menschen mit der Volkskrankheit „Rheuma“ am Beispiel der rheumatoiden Arthritis, Zeitschrift für Rheumatologie, 2011, 70, 8, 641
- 8, , The epidemiology of early inflammatory arthritis, Nature Reviews Rheumatology, 2011, 7, 7, 381
- 9, The value of early intervention in RA—a window of opportunity, Clinical Rheumatology, 2011, 30, S1, 33
- 10, , Treatment of Early Rheumatoid Arthritis: Concepts in Management, Seminars in Arthritis and Rheumatism, 2011, 40, 5, 371
- 11, , , , , , Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000–2007, Scandinavian Journal of Rheumatology, 2011, 40, 1, 16
- 12, Comment intégrer l’imagerie moderne dans le diagnostic précoce et le suivi de la polyarthrite rhumatoïde ?, Journal de Radiologie, 2010, 91, 1, 120
- 13, , Delay in receiving rheumatology care leads to long-term harm, Arthritis & Rheumatism, 2010, 62, 12Direct Link:
- 14, , , , , , , , Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis, Arthritis & Rheumatism, 2010, 62, 3Direct Link:
- 15, , Impact of tight control strategy on rheumatoid arthritis in Sarawak, Clinical Rheumatology, 2010, 30, 5, 615
- 16, , , , , , , Long-term impact of delay in assessment of patients with early arthritis, Arthritis & Rheumatism, 2010, 62, 12Direct Link:
- 17, , , , , , Neuer Ansatz zur Früherkennung entzündlich-rheumatischer Erkrankungen in der Bevölkerung, Zeitschrift für Rheumatologie, 2010, 69, 8, 743
- 18, , Optimising the strategy of care in early rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2010, 24, 4, 443
- 19, , , , Personalized medicine: the impact on chemistry, Therapeutic Delivery, 2010, 1, 5, 651
- 20, , , , , , Predictors for remission in rheumatoid arthritis patients: A systematic review, Arthritis Care & Research, 2010, 62, 8Direct Link:
- 21, , , , , , , Radiographic study on the pattern of wrist joint destruction in rheumatoid arthritis, Clinical Rheumatology, 2010, 30, 3, 353
- 22, , , , , , , , , , , , Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: A simple model of prediction from a conservatively treated community-based inception cohort, Arthritis Care & Research, 2010, 62, 12Direct Link:
- 23, , , , , , , , , , , , Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: A decision tree for clinical practice based on rheumatologists' preferences, Arthritis Care & Research, 2009, 61, 4Direct Link:
- 24, , , , , , Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment, Arthritis & Rheumatism, 2009, 60, 6Direct Link:
- 25, , , , , , , , , , Contemporary treatment principles for early rheumatoid arthritis: a consensus statement, Rheumatology, 2009, 48, 7, 765
- 26, Cytokines as Targets for Anti-inflammatory Agents, Annals of the New York Academy of Sciences, 2009, 1182, 1Direct Link:
- 27, , Drug management of early rheumatoid arthritis – 2008, Best Practice & Research Clinical Rheumatology, 2009, 23, 1, 93
- 28, , , , , , First-line DMARD choice in early rheumatoid arthritis--do prognostic factors play a role?, Rheumatology, 2009, 49, 7, 1267
- 29, , , , Multimorbidity: Prevalence, Effect on Quality of Life and Daily Functioning, and Variation of This Effect When one Condition Is a Rheumatic Disease, Seminars in Arthritis and Rheumatism, 2009, 38, 4, 312
- 30, , Predicting the development of RA in patients with early undifferentiated arthritis, Best Practice & Research Clinical Rheumatology, 2009, 23, 1, 25
- 31, The Michael Mason prize: early rheumatoid arthritis--the window narrows, Rheumatology, 2009, 49, 3, 406
- 32, , , , , , Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse, Rheumatology, 2009, 48, 9, 1092
- 33, , , , , 'I just thought it was normal aches and pains': a qualitative study of decision-making processes in patients with early rheumatoid arthritis, Rheumatology, 2008, 47, 10, 1577
- 34, Adalimumab for early rheumatoid arthritis, Expert Review of Clinical Immunology, 2008, 4, 2, 157
- 35, Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs, British Journal of Clinical Pharmacology, 2008, 66, 2Direct Link:
- 36, , , , Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohort, Rheumatology, 2008, 48, 1, 57
- 37, , , Defining Remission of Korean Patients with Rheumatoid Arthritis, The Journal of the Korean Rheumatism Association, 2008, 15, 3, 204
- 38
- 39, , , , Induction of remission in rheumatoid arthritis: criteria and opportunities, Rheumatology International, 2008, 29, 2, 131
- 40, , , Predicting the development of rheumatoid arthritis in patients with recent-onset undifferentiated arthritis, Future Rheumatology, 2008, 3, 5, 441
- 41, , The pattern and clinical manifestations of rheumatoid arthritis in Sarawak General Hospital, Clinical Rheumatology, 2008, 27, 11, 1437
- 42, , , Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs, Modern Rheumatology, 2008, 18, 3, 228
- 43, , , , , , , , A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis, Arthritis & Rheumatism, 2007, 56, 6Direct Link:
- 44, , , , , , , , , , , , Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis, Clinical Rheumatology, 2007, 26, 10, 1627
- 45, , , , Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs, Nature Clinical Practice Rheumatology, 2007, 3, 8, 450
- 46, , , , Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients, Arthritis & Rheumatism, 2007, 56, 10Direct Link:
- 47
- 48, , , , , , , Efficacy and Safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial – an Indian experience, Current Medical Research and Opinion, 2007, 23, 9, 2227
- 49, , , Electronic and computer-generated patient questionnaires in standard care, Best Practice & Research Clinical Rheumatology, 2007, 21, 4, 637
- 50, , , Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?, Internal Medicine Journal, 2007, 37, 9Direct Link:
- 51, , , , , , , , , Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis, Arthritis & Rheumatism, 2007, 56, 7Direct Link:
- 52, , , , Kooperation zwischen Hausärzten und Rheumatologen in Niedersachsen, Zeitschrift für Rheumatologie, 2007, 66, 2, 142
- 53
- 54, , , Pharmocogenetics in the future treatment of rheumatology, Future Rheumatology, 2007, 2, 4, 337
- 55, , , , , , , , , , , Response-Driven Combination Therapy with Conventional Disease-Modifying Antirheumatic Drugs Can Achieve High Response Rates in Early Rheumatoid Arthritis with Minimal Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Use, Seminars in Arthritis and Rheumatism, 2007, 37, 2, 99
- 56
- 57, , , , , , , , , , , Biological treatment in rheumatic diseases: results from a longitudinal surveillance: adverse events, Rheumatology International, 2006, 26, 10, 916
- 58, Current management of juvenile idiopathic arthritis, Best Practice & Research Clinical Rheumatology, 2006, 20, 2, 279
- 59, , , , Frühdiagnose von Arthritiden und Spondyloarthritiden im Rahmen einer Integrierten Versorgung in Niedersachsen, Zeitschrift für Rheumatologie, 2006, 65, 1, 70
- 60, , , , , , , , , , HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis, Pharmacogenetics and Genomics, 2006, 16, 9, 615
- 61, , , , Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis, Arthritis Care & Research, 2006, 55, 6Direct Link:
- 62, , , , , , , Measuring Process of Arthritis Care: The Arthritis Foundation’s Quality Indicator Set for Rheumatoid Arthritis, Seminars in Arthritis and Rheumatism, 2006, 35, 4, 211
- 63, New models of care for patients with rheumatoid arthritis, Expert Review of Pharmacoeconomics & Outcomes Research, 2006, 6, 2, 159
- 64, , Pharmacological management of transient synovitis, Expert Opinion on Pharmacotherapy, 2006, 7, 1, 35
- 65, , , , , , , , , Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression, Arthritis & Rheumatism, 2006, 54, 12Direct Link:
- 66
- 67, , , , , , , , , The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment, Arthritis & Rheumatism, 2006, 54, 1Direct Link:
- 68, , , , Treating very early rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2006, 20, 5, 849
- 69, , , , , , , , Antiâ€cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population, Scandinavian Journal of Rheumatology, 2005, 34, 5, 359
- 70, , , , , , , , , , , Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience, Rheumatology International, 2005, 26, 8, 741
- 71, , , , , , , , , , , , , , , , Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial, Arthritis & Rheumatism, 2005, 52, 11Direct Link:
- 72, , , Conventional Disease-Modifying Antirheumatic Drugs in Early Arthritis, Rheumatic Disease Clinics of North America, 2005, 31, 4, 729
- 73, , , , , , , , , , Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: Five-year experience from the FIN-RACo trial, Arthritis & Rheumatism, 2005, 52, 1Direct Link:
- 74, , , Frühdiagnose einer rheumatoiden Arthritis, Zeitschrift für Rheumatologie, 2005, 64, 8, 516
- 75, , How should we manage early rheumatoid arthritis? From imaging to intervention, Current Opinion in Rheumatology, 2005, 17, 3, 280
- 76, , Infliximab for the treatment of early rheumatoid arthritis, Expert Opinion on Biological Therapy, 2005, 5, 3, 405
- 77, , , , MRI and Musculoskeletal Ultrasonography as Diagnostic Tools in Early Arthritis, Rheumatic Disease Clinics of North America, 2005, 31, 4, 699
- 78, , Potential for Altering Rheumatoid Arthritis Outcome, Rheumatic Disease Clinics of North America, 2005, 31, 4, 763
- 79, , , , Quality of life and costs for different treatment strategies for rheumatoid arthritis, Expert Review of Pharmacoeconomics & Outcomes Research, 2005, 5, 4, 395
- 80, , Remission in Rheumatoid Arthritis: Wishful Thinking or Clinical Reality?, Seminars in Arthritis and Rheumatism, 2005, 35, 3, 185
- 81, Remodeling a Rheumatology Practice to Facilitate Early Referral, Rheumatic Disease Clinics of North America, 2005, 31, 4, 591
- 82
- 83, , , The need for new classification criteria for rheumatoid arthritis, Arthritis & Rheumatism, 2005, 52, 11Direct Link:
- 84
- 85
- 86, , , , , “The rheumatologist can see you now”: Successful implementation of an advanced access model in a rheumatology practice, Arthritis Care & Research, 2004, 51, 2Direct Link:
- 87, , Clinical trials in rheumatic diseases: designs and limitations, Rheumatic Disease Clinics of North America, 2004, 30, 4, 701
- 88, Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983–2001, Arthritis & Rheumatism, 2004, 50, 4Direct Link:
- 89, , , , , , , , , , Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: A prospective study in 154 consecutive patients, Arthritis & Rheumatism, 2004, 50, 9Direct Link:
- 90, Disease-modifying antirheumatic drugs: enhancing efficacy by combination, The Lancet, 2004, 363, 9410, 670
- 91, Epidemiology and Burden of Illness of Rheumatoid Arthritis, PharmacoEconomics, 2004, 22, Supplement 1, 1???12
- 92, , , , , , , , , , Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: Five-year experience from the FIN-RACo study, Arthritis & Rheumatism, 2004, 50, 7Direct Link:
- 93, A view of our future: The case for redesigning rheumatology practice, Arthritis Care & Research, 2003, 49, 5Direct Link:
- 94, , , , , , , , Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis, Arthritis & Rheumatism, 2003, 48, 10Direct Link:
- 95
- 96
- 97, , New Concepts in the Treatment of Rheumatoid Arthritis*, Annual Review of Medicine, 2003, 54, 1, 197
- 98, , Pharmacoepidemiology and rheumatic diseases: 2001–2002, Current Opinion in Rheumatology, 2003, 15, 2, 122
- 99
- 100, The case against haste in the treatment of rheumatoid arthritis: Comment on the editorial by Pincus et al, Arthritis & Rheumatism, 2003, 48, 2Direct Link:
- 101, Understanding the window of opportunity concept in early rheumatoid arthritis, Arthritis & Rheumatism, 2003, 48, 7Direct Link:
- 102, , , Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: Better treatments but a shortage of rheumatologists, Arthritis & Rheumatism, 2002, 46, 4Direct Link: